All patients (n = 234) | Patients with an available ECG (n = 186) | |
---|---|---|
Age | 52 (10.5) | 52 (11) |
Male sex | 162 (69%) | 133 (72%) |
Etiology of liver cirrhosis | ||
Alcoholic liver disease or mixed | 85 (36%) | 71 (38%) |
Viral liver disease | 55 (23.5%)1 | 47 (25.5%)2 |
Cholestatic liver disease | 42 (18%)3 | 33 (18%)4 |
Autoimmune hepatitis | 14 (6%) | 12 (6.5%) |
Cryptogenic/NASH cirrhosis | 20 (8.5%) | 18 (9.5%) |
Other | 18 (8%)5 | 5 (2.5%) |
Severity of liver cirrhosis | ||
Child Pugh Score | 9 (2.2) | 8.9 (2.2) |
MELD | 16.5 (6.8) | 16.2 (6.5) |
Complications of liver cirrhosis | ||
History of variceal bleeding | 59 (25%) | 45 (24%) |
Ascites at evaluation | 167 (71%) | 132 (71%) |
Hepatocellular carcinoma in explant | 26 (11%) | 23 (12.5%) |
Hepatorenal syndrome | 43 (18%) | 33 (17.5%) |
Mean arterial pressure (mmHg) | 85.5 (12) | 85 (11.5) |
Heart rate | 72 (11) | 72 (12) |
Glomerular filtration rate (ml/h/1.73sqm) | 83 (29.5) | 83 (29.5) |
CAD | 18 (8%) | 13 (7%) |
Diabetes mellitus | 28 (12%) | 37 (20%) |
History of arterial hypertension | 48 (20%) | 23 (12%) |
Current or ex-smoker | 118 (43%) | 92 (49%) |
β-Blockers at pre-transplant evaluation | 112 (48%) | 92 (49%) |
Use of diuretics at evaluation | 152 (65%) | 123 (66%) |
Coronary investigation 6 | 95 (34.5%) | 74 (40%) |